Article
MIF-2/D-DT is an atypical atherogenic chemokine that promotes advanced atherosclerosis and…
bioRxiv · 2021 · Omar El Bounkari
Key facts
| Title | MIF-2/D-DT is an atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis |
|---|---|
| First author | Omar El Bounkari |
| Journal | bioRxiv |
| Published | Dec 28, 2021 |
| DOI | 10.1101/2021.12.28.474328 |
| Devices mentioned | K040782, K781043 |
| Product codes mentioned | GIA, MVU, JAK, JRL |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1